Artificial Intelligence

Using Artificial Intelligence to Get the Right Drug to the Right Patient at the Right Time

Stefan Weiss, M.D.

Digital Health Solutions

Beyond Drug Sales: Adding Value with Digital Health

Gérard Klop; Marcos Gallego Llorente, Ph.D.

Real-World Data

Real-World Data and Artificial Intelligence are Transforming Clinical Development

Jeff Elton, Ph.D.

ConcertAI

Consulting

The Value of Data-Based Decision Making

Stephan Kutzer, Ph.D.; Danielle A. Young

AKDYS

Column: Regulatory Spotlight

New FDA Guidance on Real World Evidence/Real World Data

David Alvaro, Ph.D.

Pharma's Almanac

Real World Data

Personalized Physiology Analytics for Real-Time Insights

Chris Economos

physIQ

COVID-19 Vaccine

UBC Announces Initiative to Accelerate COVID-19 Vaccine Real-World Evidence Generation

UBC

Feature Story

Wearable Technology: Innovation, Adherence, and Clinical Outcomes

Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.

Pharma's Almanac

Feature Story

Wearable Technology: Targeting a Range of Uses and Indications

Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.

Pharma's Almanac

Feature Story

Wearable Technology: Their Future in Clinical Trials and the Real World

Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.

Pharma's Almanac

Clinical Trial Partnership

Parexel and Datavant Enter Multi-Year Strategic Partnership to Enable the Connection of Real-World Data Across All Parexel Clinical Trials

Parexel

Clinical Trials

Apple Watch to be Tested in Clinical Trial

Emilie Branch

Pharma's Almanac

Regulatory Spotlight

Understanding the FDA’s Approach to Real-World Evidence

David Alvaro, Ph.D.

Pharma's Almanac

FDA Statement

Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA's New Strategic Framework to Advance Use of Real-World Evidence to Support Development of Drugs and Biologics

U.S. Food and Drug Administration

Real World Data

Initial results from EMPRISE real-world evidence study show Jardiance® was associated with reduced risk for hospitalization for heart failure compared with DPP-4 inhibitors

Eli Lilly and Company

Big Data

The Evolution of Pharma Depends on Data Integration and Application

Nigel Walker

Nice Insight

Big Data

Big Data in Drug Development and Discovery

Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.

Pharma's Almanac

Real World Data

New Real-World Data Analyses Support the Long-Term Use of Entyvio® (vedolizumab) in Bio-Naïve Patients for the Treatment of Moderate to Severe Ulcerative Colitis or Crohn's Disease

Takeda Pharmaceuticals U.S.A., Inc.